Knowledge and opinions of orthopaedic surgeons concerning medical evaluation and treatment of patients with osteoporotic fracture

Journal of Bone and Joint Surgery

Volumn 88, Issue 1, 2006, Pages 18-24

  Skedros, John G ^a   Holyoak, Joshua D ^a   Pitts, Todd C ^a  

^a Utah Bone & Joint Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; VITAMIN D;

ADULT; AGED; ARTICLE; DIET SUPPLEMENTATION; FEMALE; FRAGILITY FRACTURE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; ORTHOPEDIC SURGERY; OSTEOPOROSIS; PATIENT CARE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; RESPONSIBILITY; SURGEON;

EID: 30344487291     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/JBJS.D.02949     Document Type: Article

References (37)

1. Rockwood PR, Horne JG, Cryer C. Hip fractures: a future epidemic? J Orthop Trauma. 1990;4:388-93.
2. Dubey A, Koval KJ, Zuckerman JD. Hip fracture epidemiology: a review. Am J Orthop. 1999;28:497-506.
3. Melton LJ 3rd, Cooper C. Magnitude and impact of osteoporosis and fractures. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. Volume 1. 2nd ed. San Diego: Academic Press; 2001. p 557-67.
4. Genant HK, Cooper C, Poor G, Reid I, Ehrlich G, Kanis J, Nordin BE, Barrett-Connor E, Black D, Bonjour JP, Dawson-Hughes B, Delmas PD, Dequeker J, Ragi Eis S, Gennari C, Johnell O, Johnston CC Jr, Lau EM, Liberman UA, Lindsay R, Martin TJ, Masri B, Mautalen CA, Meunier PJ, Miller PD, Mithal A, Morii H, Papapoulos S, Woolf A, Yu W, Khaltaev N. Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int. 1999;10:259-64.
5. Freedman KB, Kaplan FS, Bilker WB, Strom BL, Lowe RA. Treatment of osteoporosis: are physicians missing an opportunity? J Bone Joint Surg Am. 2000;82:1063-70.
6. Edwards BJ, Bunta A, Fitzpatrick L, Bolander M, Simonelli C. Hip, wrist, and lower extremity fractures predict the development of future hip fractures [abstract]. J Bone Miner Res. 2002;17 Suppl 1:S461.
7. Cuddihy MT, Gabriel SE, Crowson CS, O'Fallon WM, Melton LJ 3rd. Forearm fractures as predictors of subsequent osteoporotic fractures. Osteoporos Int. 1999;9:469-75.
8. Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res. 2000;15:721-39.
9. Ross PD, Davis JW, Epstein RS, Wasnich RD. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med. 1991;114:919-23.
10. Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, Eisman J, Fujiwara S, Garnero P, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Pols H, Reeve J, Silman A, Tenenhouse A. A meta-analysis of previous fracture and subsequent fracture risk. Bone. 2004;35:375-82.
11. United States Department of Health and Human Services; Office of the Surgeon General. Bone health and osteoporosis: a report of the Surgeon General. Rockville, MD: United States Department of Health and Human Services, Office of the Surgeon General; 2004.
12. Fleisch H. Can bisphosphonates be given to patients with fractures? J Bone Miner Res. 2001;16:437-40.
13. McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier PJ, Reginster JY. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med. 2001;344:333-40.
14. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE. Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996;348:1535-41.
15. Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, Chesnut CH 3rd, Brown J, Eriksen EF, Hoseyni MS, Axelrod DW, Miller PD. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA. 1999;282:1344-52.
16. Miller P. Analysis of 1-year vertebral fracture risk reduction data in treatments for osteoporosis. South Med J. 2003;96:478-85.
17. Harrington JT, Ste-Marie LG, Brandi ML, Civitelli R, Fardellone P, Grauer A, Barton I, Boonen S. Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis. Calcif Tissue Int. 2004;74:129-35.
18. Watts NB, Cooper C, Lindsay R, Eastell R, Manhart MD, Barton IP, van Staa TP, Adachi JD. Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk. J Clin Densitom. 2004;7:255-61.
19. Munns CF, Rauch F, Zeitlin L, Fassier F, Glorieux FH. Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate. J Bone Miner Res. 2004;19:1779-86.
20. Simonelli C, Killeen K, Mehle S, Swanson L. Barriers to osteoporosis identification and treatment among primary care physicians and orthopedic surgeons. Mayo Clin Proc. 2002;77:334-8.
21. Tosi LL, Lane JM. Osteoporosis prevention and the orthopaedic surgeon: when fracture care is not enough. J Bone Joint Surg Am. 1998;80:1567-9.
22. Lane JM, Nydick M. Osteoporosis: current modes of prevention and treatment. J Am Acad Orthop Surg. 1999;7:19-31.
23. Pal B, Morris J, Muddu B. The management of osteoporosis-related fractures: a survey of orthopaedic surgeons' practice. Clin Exp Rheumatol. 1998;16:61-2.
24. Gardner MJ, Flik KR, Mooar P, Lane JM. Improvement in the undertreatment of osteoporosis following hip fracture. J Bone Joint Surg Am. 2002;84:1342-8.
25. Skedros JG, Milleson NM. The orthopaedic surgeon as a clinical densitometrist: evaluation of cost and time effectiveness. Osteoporos Int. 2002;13 Suppl 1:S128.
26. Kaufman JD, Bolander ME, Bunta AD, Edwards BJ, Fitzpatrick LA, Simonelli C. Barriers and solutions to osteoporosis care in patients with a hip fracture. J Bone Joint Surg Am. 2003;85:1837-43.
27. Dreinhofer KE, Feron JM, Herrera A, Hube R, Johnell O, Lidgren L, Miles K, Panarella L, Simpson H, Wallace WA. Orthopaedic surgeons and fragility fractures: a survey by the Bone and Joint Decade and the International Osteoporosis Foundation. J Bone Joint Surg Br. 2004;86:958-61.
28. Dreinhofer KE, Anderson M, Feron JM, Herrera A, Hube R, Johnell O, Lidgren L, Miles K, Tarantino U, Simpson H, Wallace WA. Multinational survey of osteoporotic fracture management. Osteoporos Int. 2005;16 Suppl 2:S44-53.
29. Skedros JG. The orthopaedic surgeon's role in diagnosing and treating patients with osteoporotic fractures: standing discharge orders may be the solution for timely medical care. Osteoporos Int. 2004;15:405-10.
30. Dillman D. Mail and internet surveys: the tailored design method. 2nd ed. New York: Wiley; 2000.
31. Conover WJ. Practical nonparametric statistics. 2nd ed. New York: Wiley; 1980. p 165-9.
32. Siegel S, Castellan NJ Jr. Nonparametric statistics for the behavioral sciences. 2nd ed. New York: McGraw-Hill; 1988. p 128-37.
33. Jann B. Tabulation of multiple responses. Stata J. 2005;5:92-122.
34. Lin JT, Lane JM. Osteoporosis: a review. Clin Orthop Relat Res. 2004; 425:126-34.
35. McLellan AR, Gallacher SJ, Fraser M, McQuillian C. The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int. 2003;14:1028-34.
36. Ridout R, Hawker GA, Mahomed N, Bogoch ER. An intervention to increase investigation and treatment of osteoporosis in fragility fracture patients [abstract]. J Bone Miner Res. 2000;15 Suppl 1:S294.
37. Jaglal S, Hawker G, Bogoch E, Cadarette S, Carroll J, Davis D, Jaakkimainen L, Kreder H, McIsaac W. Development of a model of integrated post-fracture care [abstract]. J Bone Miner Res. 2004;19 Suppl 1:S163.